1 Product identity
Ingredient risk
1 ingredient to use with caution
Phenocane Curcumin & DLPA
BrandOxyLife Nutritional Supplements→Other Combinations Capsule 6 ingredients 1 caution DSLD #16975Net contents: 60 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-01-25
2 Ingredients (6)
IngredientGroupSafety
CurcuminCurcumin—
Vegetable Capsulescapsule—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
L-Phenylalanine — Limited Evidence
⚠ Dangerous in PKU
⚠ May raise blood pressure
Boswellia — Generally Safe
⚠ GI discomfort
⚠ May enhance anticoagulants
Nattokinase — Conditionally Safe
⚠ Anticoagulant/fibrinolytic effect
⚠ Increased bleeding risk
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID16975
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-01-25
6 More from OxyLife Nutritional Supplements
7 Cite this page
Vancouver
Pkhakadze G. Phenocane Curcumin & DLPA — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/phenocane-curcumin-dlpa-16975/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG